The marked global variation in both the incidence of gastric cancer ([1,2,3], Table 1) and the global variability in the frequency of cag PAI-positive H. pylori strains [60] are important factors to consider when assessing the relative risk of infection with CagA-positive H. pylori strains and distal gastric cancer. The gene discussed is S100A8; the disease is infection.